This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1968 Feb 24;1(5590):484-5.

doi: 10.1136/bmj.1.5590.484.

Colistin sulphomethate sodium administration in the presence of severe renal failure and during haemodialysis and peritoneal dialysis

J R Curitis, J B Eastwood

PMID: 5643721
PMCID: PMC1985197
DOI: 10.1136/bmj.1.5590.484

Colistin sulphomethate sodium administration in the presence of severe renal failure and during haemodialysis and peritoneal dialysis

J R Curitis et al. Br Med J. 1968.

. 1968 Feb 24;1(5590):484-5.

doi: 10.1136/bmj.1.5590.484.

Authors

J R Curitis, J B Eastwood

PMID: 5643721
PMCID: PMC1985197
DOI: 10.1136/bmj.1.5590.484

No abstract available

PubMed Disclaimer

Similar articles

The effects of renal impairment, peritoneal dialysis, and hemodialysis on serum sodium colistimethate levels.
Goodwin NJ, Friedman EA. Goodwin NJ, et al. Ann Intern Med. 1968 May;68(5):984-94. doi: 10.7326/0003-4819-68-5-984. Ann Intern Med. 1968. PMID: 5646830 Clinical Trial. No abstract available.
Carbenicillin administration in patients with severe renal failure.
Eastwood JB, Curtis JR. Eastwood JB, et al. Br Med J. 1968 Feb 24;1(5590):486-7. doi: 10.1136/bmj.1.5590.486. Br Med J. 1968. PMID: 4868467 Free PMC article. Clinical Trial. No abstract available.
The dynamics of serum myoinositol concentration changes during haemodialysis and peritoneal dialysis.
Trznadel K, Walasek L, Waldemar L. Trznadel K, et al. Acta Med Pol. 1977;18(1):55-61. Acta Med Pol. 1977. PMID: 855681 No abstract available.
Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
Teruel-Briones JL, Fernández-Lucas M, Rivera-Gorrin M, Ruiz-Roso G, Díaz-Domínguez M, Rodríguez-Mendiola N, Quereda-Rodríguez-Navarro C. Teruel-Briones JL, et al. Nefrologia. 2013;33(5):640-9. doi: 10.3265/Nefrologia.pre2013.May.12038. Nefrologia. 2013. PMID: 24089155 Clinical Trial. English, Spanish.
Drug therapy in renal failure: dosing guidelines for adults. Part I: Antimicrobial agents, analgesics.
Bennett WM, Muther RS, Parker RA, Feig P, Morrison G, Golper TA, Singer I. Bennett WM, et al. Ann Intern Med. 1980 Jul;93(1):62-89. doi: 10.7326/0003-4819-93-1-62. Ann Intern Med. 1980. PMID: 6994534 Review.

See all similar articles

Cited by

In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
Li J, Turnidge J, Milne R, Nation RL, Coulthard K. Li J, et al. Antimicrob Agents Chemother. 2001 Mar;45(3):781-5. doi: 10.1128/AAC.45.3.781-785.2001. Antimicrob Agents Chemother. 2001. PMID: 11181360 Free PMC article.
Use of intravenous polymyxin B during continuous venovenous hemodialysis.
Sarria JC, Angulo-Pernett F, Kimbrough RC, McVay CS, Vidal AM. Sarria JC, et al. Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):340-1. doi: 10.1007/s10096-004-1106-8. Epub 2004 Mar 6. Eur J Clin Microbiol Infect Dis. 2004. PMID: 15007705
Pharmacokinetics of colistin methanesulfonate and formed colistin in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis.
Koomanachai P, Landersdorfer CB, Chen G, Lee HJ, Jitmuang A, Wasuwattakul S, Sritippayawan S, Li J, Nation RL, Thamlikitkul V. Koomanachai P, et al. Antimicrob Agents Chemother. 2014;58(1):440-6. doi: 10.1128/AAC.01741-13. Epub 2013 Nov 4. Antimicrob Agents Chemother. 2014. PMID: 24189256 Free PMC article.
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies.
Falagas ME, Kasiakou SK. Falagas ME, et al. Crit Care. 2006 Feb;10(1):R27. doi: 10.1186/cc3995. Crit Care. 2006. PMID: 16507149 Free PMC article.

References

1. Ann Intern Med. 1967 Mar;66(3):465-70 - PubMed
1. Lancet. 1962 Oct 13;2(7259):737-9 - PubMed
1. Br Med J. 1963 Sep 28;2(5360):790-2 - PubMed
1. N Engl J Med. 1964 Feb 20;270:394-7 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Molecular Biology Databases
- BacDive